President Trump Announces Nationwide Medicaid Drug Pricing Model
President Donald Trump announced that all 50 states would participate in a Medicaid drug pricing model, referred to as the Medicaid “GENEROUS” model, which aims to lower prescription drug costs by linking them to prices paid in other countries. The…
Las Vegas, NV, September 18, 2026 —
President Donald Trump has announced that all 50 states will participate in a new prescription drug pricing model for the Medicaid program. This initiative, termed the Medicaid “GENEROUS” model, is designed to reduce the cost of prescription drugs by pegging them to international pricing benchmarks.
The Trump administration has projected that this model will result in substantial savings for the Medicaid program. The Las Vegas Sun News has reported on this development.
The core objective of the Medicaid “GENEROUS” model is to align the prices paid for certain prescription drugs with what is charged in other developed nations. By leveraging international price comparisons, the administration aims to achieve lower drug expenditures within the United States’ largest public health insurance program for low-income individuals and families.
The announcement signifies a nationwide rollout, indicating that every state has agreed to implement the pricing strategy. This broad participation is expected to create a unified approach to drug cost management across the country within the Medicaid system.
Details regarding the specific timeline for implementation across all 50 states, the exact methodology for determining the linked international prices, or the precise projected savings figures were not detailed in the summary provided.
The Las Vegas Sun News has been identified as a media outlet that covered the announcement of this initiative.
Story summarized from the original created by Associated Press on lasvegassun.com, see more information here.
Media gallery
